Key ophthalmic organisations have revealed their federal election wish lists, drawing attention to issues such as workforce maldistribution and access for rural and remote communities, which optometrists say could be partially alleviated with an expedited decision around oral medication prescribing and involvement in intravitreal injection (IVI) services. Read more
Newly-formed organisation Optical Dispensers Australia (ODA) has partnered with various optical companies who are supporting the organisation’s goal to enhance the national optical dispensing profession. Read more
Virtual optometry conference Optometry Virtually Connected is returning in June, with Optometry Australia (OA) securing a preeminent US academic in contact lenses and myopia as its keynote speaker, alongside other esteemed speakers. Read more
Alcon has expanded its range of preservative-free eye drops with the addition of Systane Complete Preservative-free. The lubricating eye drop combines the long-lasting formulation of Systane Complete with a multi-dose, preservative-Free bottle, the company announced. Read more
The Centre for Ocular Research & Education (CORE) has published Issue 64 of Contact Lens Update, exploring risks associated with lens wear non-compliance and insights to improve patient behaviours. Read more
About 5000 people are expected to participate in Australia’s first national survey combining ear and eye health, launched on 3 March to coincide with World Hearing Day. Read more
Fresh findings from the 2021 Medical Training Survey (MTS) show one in five ophthalmology trainees have experienced bullying, harassment and discrimination, with 92% opting not to report it. Long work hours also remain an issue, with the average RANZCO trainee working 49.7 hours. Read more
RANZCO’s inaugural virtual congress has been hailed “a huge success”, with hundreds of delegates tuning in to view four days of lectures and events that will remain available on-demand for the next three months. Read more
Welcome to People on the move – March 2022, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and personnel changes. Read more
The Therapeutic Goods Administration (TGA) has granted Lucentis (ranibizumab) an indication for retinopathy of prematurity (ROP), making it the first anti-VEGF therapy approval for the rare disease affecting premature infants in Australia. Read more